Boron neutron capture therapy using dodecaborated albumin conjugates with maleimide is effective in a rat glioma model
Conclusion MID-AC induces an efficient boron neutron capture reaction because the albumin contained in MID-AC is retained in the tumor and has a considerable potential to become an effective delivery system for BNCT in treating high-grade gliomas.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Drugs & Pharmacology | Glioma | Investigational New Drugs | Neurology | Statistics | Study